The new collaboration brings global expertise in advanced hair restoration to the UAE through Burjeel’s premium cosmetics and aesthetics brand, Tajmeel Dubai, March 28, 2026: Burjeel Holdings, a leading super-specialty healthcare services provider in the MENA, has announced a strategic collaboration through its premium cosmetics and aesthetics brand, Tajmeel, with Türkiye-based Suzermed Clinic, a specialist provider … Continue reading Burjeel Holdings’ Tajmeel Partners with Türkiye’s Suzermed Clinic to Launch Specialized Hair Transplant Clinic in UAE
Category: Health Care
بمناسبة شهر التوعية لسرطان القولون والمستقيم، مركز ميموريال سلون كيترنغ لعلاج السرطان يستعرض أحدث التطورات العلاجية
بمناسبة شهر التوعية لسرطان القولون والمستقيم، مركز ميموريال سلون كيترنغ لعلاج السرطان يستعرض أحدث التطورات العلاجية الابتكار العالمي في علاج سرطان القولون والمستقيم يخدم الحاجة المتزايدة في الخليج و منطقة الشرق الأوسط دبي، الرياض، الدوحة – 26 مارس 2026 بمناسبة شهر التوعية لسرطان القولون والمستقيم، يسلّط مركز ميموريال سلون كيترنغ لعلاج السرطان الضوء على التقدم … Continue reading بمناسبة شهر التوعية لسرطان القولون والمستقيم، مركز ميموريال سلون كيترنغ لعلاج السرطان يستعرض أحدث التطورات العلاجية
During Colorectal Cancer Awareness Month, Memorial Sloan Kettering Cancer Center Showcases New Advances in Care
Global innovation in colorectal cancer care meets growing regional need in the Middle East DUBAI, RIYADH, DOHA, March 26, 2026. During Colorectal Cancer Awareness Month, Memorial Sloan Kettering Cancer Center (MSK) is spotlighting advances in colorectal cancer care, while emphasizing the importance of screening, early detection, and access to specialized treatment for patients across the … Continue reading During Colorectal Cancer Awareness Month, Memorial Sloan Kettering Cancer Center Showcases New Advances in Care
Novo Nordisk A/S: Wegovy® HD (semaglutide 7.2 mg) approved in the US, providing 20.7% mean weight loss
Dubai, 24 March 2026 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Wegovy® HD (once-weekly injectable semaglutide 7.2 mg) to reduce excess body weight and maintain weight reduction long-term. The FDA awarded a Commissioner’s National Priority Voucher for Wegovy® HD, accelerating its review and underscoring its potential to address critical patient … Continue reading Novo Nordisk A/S: Wegovy® HD (semaglutide 7.2 mg) approved in the US, providing 20.7% mean weight loss
Burjeel Opens New Medical Center in Dubai Silicon Oasis, Announces AED 1 Million Community Health Initiative
The center was opened by Mr. Yusuff Ali M.A., who said confidence in the UAE remains strong and businesses will continue to grow Dubai, March 22, 2026: Burjeel Holdings, a leading super-specialty healthcare services provider in MENA, has opened its new Burjeel Medical Center at Silicon Central Mall in Dubai Silicon Oasis, expanding its network of … Continue reading Burjeel Opens New Medical Center in Dubai Silicon Oasis, Announces AED 1 Million Community Health Initiative
